fashion -WSS

fashion

author：knowledge 2025-10-01 21:09:30 - browse：49179

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

hotspot

WSS

Biogen’s boardroom scandal saddles CEO with first crisis

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Supreme Court to hear if Covid misinformation is protected speech

Maui wildfire now ranks as the fifth

Fertility clinic egg and embryo storage is a disaster

What to know about the judge who will handle the Trump case

focus

fashion

leisure time

Virginia high school admissions case could be legal follow

STAT reporters are Pulitzer Prize finalists for investigative reporting

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Patients, digital health players weigh in on FTC's data privacy plan

Tori Bowie and the unacceptable rates of Black maternal death

BMS, looking to build heart drug business, turns to AI for diagnosis

What does generative AI mean for health care? We asked experts

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Medicare details structure of new drug price negotiation program

Indictment alleges Trump's ex

knowledge

Biden administration begins canceling student loan debt for 804,000 borrowers

Cherokee Nation medical school graduates its first class

Bird flu researchers hone in on Finland’s mink farms

WuXi Biologics execs register to lobby as Congress comes for the company

Galapagos to make CAR

Boston hospital trains restaurant workers on naloxone for overdoses

entertainment

hotspot

focus

focus